Emily C. Dykhuizen
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
Publications
85
Citations
2,525
Est. group size
~18
Recurring co-author estimate
Active years
24
Publishing since 2003
Emily C. Dykhuizen's research focuses on chromatin remodeling complexes—large protein machines that control which genes are turned on or off by repackaging DNA—particularly the SWI/SNF (BAF) family and their roles in cancer. Her lab studies how mutations in subunits like PBRM1, ARID1A, and BRD7 affect protein function, gene regulation, and immune signaling, and develops small-molecule chemical probes and inhibitors that target specific 'reader' domains (such as bromodomains) to block these proteins' activity, especially in prostate cancer and other tumor types. This work combines structural biology, biochemistry, and drug discovery approaches to understand and potentially treat cancers driven by chromatin regulator mutations.
Publication output has fluctuated over the past decade with a peak in 2018 and another surge in 2023, averaging just under 7 papers per year over the last five years without a clear sustained upward or downward trend.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Structural landscape of H3K27me3 recognition by protein domains and their potential for inhibition
Journal of Biological Chemistry · 2026
- Abstract 1808 The development of chemical probes of histone “reader” subunits of chromatin remodeling complexes
Journal of Biological Chemistry · 2025
- ARID1A suppresses R-loop-mediated STING-type I interferon pathway activation of anti-tumor immunity
Cell · 2024
- Collaboration between distinct SWI/SNF chromatin remodeling complexes directs enhancer selection and activation of macrophage inflammatory genes
Immunity · 2024
- Cancer-associated polybromo-1 bromodomain 4 missense variants variably impact bromodomain ligand binding and cell growth suppression
Journal of Biological Chemistry · 2024
- SWI/SNF chromatin remodelers in prostate cancer progression
Frontiers in Epigenetics and Epigenomics · 2024
- PBRM1 bromodomains associate with RNA to facilitate chromatin association
Nucleic Acids Research · 2023
- Rational Design and Development of Selective BRD7 Bromodomain Inhibitors and Their Activity in Prostate Cancer
Journal of Medicinal Chemistry · 2023
- Activity-assembled nBAF complex mediates rapid immediate early gene transcription by regulating RNA Polymerase II productive elongation
bioRxiv (Cold Spring Harbor Laboratory) · 2023
- Rational design and development of selective BRD7 bromodomain inhibitors and their activity in prostate cancer
ChemRxiv · 2023
- Abstract 1294: Cancer-associated missense mutations in the tumor suppressor Polybromo-1 variably affect protein stability and function
Journal of Biological Chemistry · 2023
- Selective and Cell-Active PBRM1 Bromodomain Inhibitors Discovered through NMR Fragment Screening
Journal of Medicinal Chemistry · 2022
- PBRM1 BD2 and BD4 associate with RNA to facilitate chromatin association
bioRxiv (Cold Spring Harbor Laboratory) · 2022
- Design and Synthesis of Bi‐aryl Methylated Lactam Derivatives to Inhibit the BRD7 Bromodomain Function in Prostate Cancer
The FASEB Journal · 2022
- Polybromo‐1 missense mutations found in renal cancer patients affect bromodomain stability and biological function
The FASEB Journal · 2022
- bioRxiv (Cold Spring Harbor Laboratory)×8
- Journal of Biological Chemistry×6
- ChemRxiv×4
- The FASEB Journal×4
- ACS Chemical Biology×2
- Yu‐Chun Tseng
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Surbhi Sood
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Alisha Dhiman
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Benjamin C. Carter
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Ashley Gray
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile